Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia
- 31 October 2007
- Vol. 90 (4) , 464-473
- https://doi.org/10.1016/j.ygeno.2007.06.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Metabolic and Cardiovascular Complications of Highly Active Antiretroviral Therapy for HIV InfectionCurrent HIV Research, 2006
- The effect of low‐dose ritonavir monotherapy on fasting serum lipid concentrationsHIV Medicine, 2005
- Adverse effects of antiretroviral therapy for HIV infection: a review of selected topicsExpert Opinion on Drug Safety, 2005
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Abnormal fat distribution and use of protease inhibitorsThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical EfficacyJournal of Medicinal Chemistry, 1998
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995